REFERENCES
- Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends on obesity among US adults, 1999–2000. JAMA 2002; 288: 1723–1727, [INFOTRIEVE], [CSA]
- Baskin ML, Ard J, Franklin F, Allison DB. National prevalence of obesity in the United States. Obesity Reviews 2005; 6: 5–7, [INFOTRIEVE], [CROSSREF], [CSA]
- Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498–1509, [INFOTRIEVE], [CROSSREF], [CSA]
- Scaglione R, Ganguzza A, Corrao S, et al. Central obesity and hypertension: Pathophysiologic role of renal haemodynamics and function. Int J Obes Relat Metab Disord 1995; 19: 403–409, [INFOTRIEVE], [CSA]
- Must A, Spadona J, Coakley FH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523–1529, [INFOTRIEVE], [CROSSREF], [CSA]
- Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 1995; 26: 610–615, [INFOTRIEVE], [CSA]
- Porter LE, Hollenberg NK. Obesity, salt intake and renal perfusion in healthy humans. Hypertension 1998; 32: 144–148, [INFOTRIEVE], [CSA]
- Hall JE, Henegar JR, Dwyer TM, et al. Is obesity a major cause of chronic kidney disease?. Adv Ren Replace Ther 2004; 11: 41–54, [INFOTRIEVE], [CROSSREF], [CSA]
- Valensi P, Assayag M, Busby M, Paries J, Lormeau B, Attali JR. Microalbuminuria in obese patients with or without hypertension. Int J Obes Relat Metab Disord 1996; 20: 574–579, [INFOTRIEVE], [CSA]
- Hall JE, Guyton AC, Smith MJ, Coleman TG. Blood pressure and renal function during chronic changes in sodium intake: Role of angiotensin. Am J Phys 1980; 239: 271–280, [CSA]
- Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132: 501–513, [INFOTRIEVE], [CSA]
- Stamler J. Epidemiologic findings on body mass and blood pressure in adults. Ann Epidemiol 1991; 1: 347–362, [INFOTRIEVE], [CSA]
- National Institutes of Health. United States Renal Data System: 1994 Annual Report. University of Michigan, Ann Arbor, Michigan 1995
- Mulyadi L, Stevens C, Munro S, Lingard J, Bermingham M. Body fat distribution and total body fat as risk factors for microalbuminuria in the obese. Ann Nutr Metab 2001; 45: 67–71, [INFOTRIEVE], [CROSSREF], [CSA]
- Cirillo M, Senigalliesi L, Laurenzi M, et al. Microalbuminuria in nondiabetic adults: Relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. Arch Intern Med 1998; 158: 1933–1939, [INFOTRIEVE], [CROSSREF], [CSA]
- Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 2003; 16: 952–958, [INFOTRIEVE], [CROSSREF], [CSA]
- De Onis M, Habicht JP. Anthropometric reference data for international use: recommendations from a World Health Organization expert committee. Am J Clin Nutr 1996; 64: 650–658, [INFOTRIEVE], [CSA]
- Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarod K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD. Are men more vulnerable?. Am J Kidney Dis 2006; 47: 396–405, [INFOTRIEVE], [CROSSREF], [CSA]
- Wiggins KJ, Johnson DW. The influence of obesity on the development and survival outcomes of chronic kidney disease. Adv Chronic Kidney Dis 2005; 12: 49–55, [INFOTRIEVE], [CROSSREF], [CSA]
- Tofovic SP, Kusaka H, Kost K, Bastacky S. Renal function and structure in diabetic, hypertensive, obese ZDFxSHHF-hybrid rats. Ren Fail 2000; 22(4)387–406, [INFOTRIEVE], [CROSSREF], [CSA]
- Hall JE. Pathophysiology of obesity hypertension. Curr Hypertens Rep 2000; 2: 139–147, [INFOTRIEVE], [CSA]
- Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM. Mechanisms of obesity associated cardiovascular and renal disease. Am J Med Sci 2002; 324: 127–137, [INFOTRIEVE], [CROSSREF], [CSA]
- Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000; 278: 817–822, [CSA]
- De Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL. Obesity and target organ damage: The kidney. Int J Obes 2002; 26(Suppl, 4)S21–S24, [CROSSREF], [CSA]
- Atkins RC, Polkinghorne KR, Briganti EM, Shaw JE, Zimmet PZ, Chadban SJ. Prevalence of albuminuria in Australia: the AusDiab Kidney Study. Kidney Int 2004; 92: 22–24, [CROSSREF], [CSA]
- Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003; 63: 1468–1474, [INFOTRIEVE], [CROSSREF], [CSA]
- Basdevant A, Cassuto D, Gibault T, Raison J, Guy-Grand B. Microalbuminuria and body fat distribution in obese subjects. Int J Obes Relat Metab Disord 1994; 18: 806–811, [INFOTRIEVE], [CSA]
- Kasiske BL, Napier J. Glomerular sclerosis in patients with massive obesity. Am J Nephrol 1985; 5: 45–50, [INFOTRIEVE], [CSA]